RIL, Paytm, Axis Bank, Sun Pharma among buzzing stocks as NIFTY50, SENSEX gain nearly 1%
The stock of Cohance Lifesciences hit its 20% upper limit at ₹432.10 per unit on the NSE, after it announced the appointment of the former Cipla CEO, Umang Vohra, as its Executive Chairman, effective May 1, 2026, and Group CEO, effective May 20, 2026.
The stock of Cohance Lifesciences hit its 20% upper limit at ₹432.10 per unit on the NSE, after it announced the appointment of the former Cipla CEO, Umang Vohra, as its Executive Chairman, effective May 1, 2026, and Group CEO, effective May 20, 2026.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
